Announcement: Aurelia Bioscience has been acquired by Charnwood Molecular.

Share this

Known colloquially as the “Hatfield MedChem” meeting, this long-standing, one-day meeting runs annually. The scientific program will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics from the forefront of drug discovery of relevance to medicinal chemists.

If you are there and would like to know how Charnwood Molecular can contribute to your integrated drug discovery projects with biology and chemistry, contact Phil Thorne or Rhydian Beddoe at the event.